Back to News
Market Impact: 0.32
Medtronic: Don't Miss Out On This Dividend Aristocrat Deal Now
Source: seekingalpha.com
Corporate EarningsCorporate Guidance & OutlookCompany FundamentalsHealthcare & Biotech
Medtronic outperformed the S&P 500 in recent months and delivered a strong Q1 FY2027 performance, prompting an increase in its non-GAAP EPS guidance for the full fiscal year. The company’s healthy interest-coverage and net-debt-to-EBITDA ratios support a favorable financial-risk profile alongside improving earnings expectations.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.58
Ticker Sentiment
MDT0.72
More News
- South Korean solar stocks jump as curbs on Chinese sector expected to remain in place
- Paramount will need to release way more movies to make this merger work
- Meta is breaking out after introducing Muse AI agent. Where the stock is going, according to the charts
- Australia’s IDP shares drop after rejecting $494 mln Blackstone offer
- Lennar shares pop as Berkshire builds almost a 10% stake in beleaguered homebuilder
- Royal Caribbean nears $3 billion deal to take 50% equity stake in Sandals